BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 3239956)

  • 1. Paraneoplastic cerebellar degeneration: clinical-immunological correlations.
    Anderson NE; Rosenblum MK; Posner JB
    Ann Neurol; 1988 Oct; 24(4):559-67. PubMed ID: 3239956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Paraneoplastic cerebellar degeneration--characterization of anti-Yo antibody and underlying cancer].
    Tanaka K; Tanaka M; Onodera O; Tsuji S
    Rinsho Shinkeigaku; 1995 Jul; 35(7):770-4. PubMed ID: 8777801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Paraneoplastic cerebellar degeneration].
    Chabriat H; Chen QM; Poisson M; Delattre JY
    Rev Neurol (Paris); 1994; 150(2):105-14. PubMed ID: 7863150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Paraneoplastic cerebellar degeneration].
    Nakano R; Sato S
    Nihon Rinsho; 1994 Nov; 52(11):3000-5. PubMed ID: 7996701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Subacute paraneoplastic cerebellar degeneration with anti-neuronal antibodies and gynecological cancers. A case report of a bilateral ovarian cancer where the classic "anti-YO" antibody is associated with another antineuronal antibody].
    Tremouilhac C; Hamy A; De Ferron E; Paineau J; Visset J
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(3):253-6. PubMed ID: 8767221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration.
    Furneaux HM; Rosenblum MK; Dalmau J; Wong E; Woodruff P; Graus F; Posner JB
    N Engl J Med; 1990 Jun; 322(26):1844-51. PubMed ID: 2348838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of paraneoplastic cerebellar degeneration--success in early detection of cancer by anti-Purkinje cell antibody].
    Igarashi S; Tanaka K; Nakajima T; Yamazaki M; Inuzuka T; Miyatake T
    Rinsho Shinkeigaku; 1992 Mar; 32(3):309-13. PubMed ID: 1628454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraneoplastic anti-Purkinje and type I anti-neuronal nuclear autoantibodies bind selectively to central, peripheral, and autonomic nervous system cells.
    Altermatt HJ; Rodriguez M; Scheithauer BW; Lennon VA
    Lab Invest; 1991 Oct; 65(4):412-20. PubMed ID: 1921331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Paraneoplastic cerebellar degeneration: case report of a patient with breast carcinoma].
    Huober J; Niedermaier N; Drlicek M; Kaufmann M; Hacke W; Bastert G
    Geburtshilfe Frauenheilkd; 1996 Apr; 56(4):214-6. PubMed ID: 8682288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective concentration of anti-Purkinje cell antibody in the CSF of two patients with paraneoplastic cerebellar degeneration.
    Graus F; Segurado OG; Tolosa E
    Acta Neurol Scand; 1988 Sep; 78(3):210-3. PubMed ID: 3227806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A variant of the anti-Purkinje cell antibody in a patient with paraneoplastic cerebellar degeneration.
    Anderson NE; Budde-Steffen C; Wiley RG; Thurman L; Rosenblum MK; Nadeau SE; Posner JB
    Neurology; 1988 Jul; 38(7):1018-26. PubMed ID: 3290700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunobiological approach to spinocerebellar degeneration--anti-Purkinje cell antibodies in paraneoplastic cerebellar degeneration].
    Miyatake T
    Rinsho Shinkeigaku; 1993 Dec; 33(12):1291-3. PubMed ID: 8174327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neurologic paraneoplastic syndromes and anti-neuronal antibodies].
    Mygland A
    Tidsskr Nor Laegeforen; 1996 Jan; 116(3):361-5. PubMed ID: 8638263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Purkinje cell antibody (PCA-2): marker of lung cancer-related neurological autoimmunity.
    Vernino S; Lennon VA
    Ann Neurol; 2000 Mar; 47(3):297-305. PubMed ID: 10716248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Purkinje cells antibodies in two cases of paraneoplastic cerebellar degeneration.
    Sindic CJ; Andersson M; Boucquey D; Chalon MP; Bisteau M; Brucher JM; Laterre EC
    Acta Neurol Belg; 1993; 93(2):65-77. PubMed ID: 8506746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An antineuronal autoantibody in paraneoplastic opsoclonus.
    Budde-Steffen C; Anderson NE; Rosenblum MK; Graus F; Ford D; Synek BJ; Wray SH; Posner JB
    Ann Neurol; 1988 May; 23(5):528-31. PubMed ID: 3389761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Autoimmune paraneoplastic cerebellar degeneration].
    Lövblad KO; Henny C; Boucraut J; Graus F; Delaloye JF; Bernard D; Steck AJ; Regli F
    Rev Neurol (Paris); 1994; 150(1):46-9. PubMed ID: 7801040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure to detect cytotoxic T cell activity against recombinant Yo protein using autologous dendritic cells as the target in a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody.
    Tanaka M; Tanaka K; Idezuka J; Tsuji S
    Exp Neurol; 1998 Apr; 150(2):337-8. PubMed ID: 9527904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antineuronal autoantibody to a 40-kDa protein in a patient with cerebellar ataxia and breast cancer].
    Kaneko A; Nishikiori E; Imai A; Hosokawa T; Hamaguchi K
    Rinsho Shinkeigaku; 1995 Mar; 35(3):277-81. PubMed ID: 7614751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Autoimmunity and paraneoplastic neurologic syndromes].
    Delattre JY; Davila L; Vega F; Poisson M
    Rev Neurol (Paris); 1991; 147(8-9):549-56. PubMed ID: 1962063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.